CIK 0001706431
- Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812730369
- Phone
- +1 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- 4 Planned sale Director sold 22,000 shares at $9.07 ($199,617)
- 4 Planned sale SVP, Chief Accounting Officer sold 7,711 shares at $9.12 ($70,324)
- 4 Other disposition EVP & Chief Financial Officer disposed of 2,500 shares (other)
- 4 Planned sale Director sold 22,000 shares at an average $9.51 ($209,181)
- 4 Planned sale Director sold 42,377 shares at an average $9.75 ($413,366)
- 4 Planned sale SVP, Chief Accounting Officer sold 1,430 shares at $9.53 ($13,632)
- 4 Planned sale EVP & Chief Financial Officer sold 1,634 shares at $9.53 ($15,576)
- 4 Planned sale EVP and Chief Medical Officer sold 3,505 shares at an average $9.69 ($33,955)
- 4 Planned sale EVP, General Counsel, Corp Sec sold 16,817 shares at an average $9.77 ($164,247)
- 4 Planned sale Chief Executive Officer sold 14,762 shares at $9.53 ($140,720)
- 4 Planned sale SVP, Chief Accounting Officer sold 1,829 shares at $7.45 ($13,631)
- 4 Planned sale EVP & Chief Financial Officer sold 2,089 shares at $7.45 ($15,569)
- 4 Planned sale EVP and Chief Medical Officer sold 2,089 shares at $7.45 ($15,569)
- 4 Planned sale EVP, General Counsel, Corp Sec sold 4,445 shares at $7.45 ($33,128)
- 4 Planned sale Chief Executive Officer sold 19,039 shares at $7.45 ($141,894)
- 4 Planned sale SVP, Chief Accounting Officer sold 1,530 shares at $7.79 ($11,919)
- 4 Planned sale Director sold 22,000 shares at $7.71 ($169,671)
- 4 Planned sale Director sold 22,000 shares at $5.93 ($130,383)
- 4 Planned sale 10% owner sold 191,854 shares at $5.98 ($1,147,786)
- 4 Planned sale Director sold 22,000 shares at $6.00 ($132,070)
Page 2 of 25 · 491 filings